# EXTEND (International): Extending the Time for Thrombolysis in Emergency Neurological Deficits (International)

> **NCT01580839** · PHASE3 · COMPLETED · sponsor: **Neuroscience Trials Australia** · enrollment: 45 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Tissue Plasminogen Activator (Alteplase)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01580839
- **Lead sponsor:** Neuroscience Trials Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-06
- **Primary completion:** 2018-08-22
- **Final completion:** 2018-08-22
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2018-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01580839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01580839, "EXTEND (International): Extending the Time for Thrombolysis in Emergency Neurological Deficits (International)". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT01580839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*